Researchers increasingly seek a quick, efficient, and cost-effective solution to genome sequencing that helps them overcome workflow bottlenecks and resource…
Investments in neurodegeneration-focused startups set to continue as Sanofi Ventures gets significant cash infusion. Pharma giant Sanofi has revealed it…
